Modulating signaling pathways in hypertrophy and heart failure by gene transfer

Journal of Cardiac Failure

Volumn 8, Issue 6 SUPPL., 2002, Pages

  Huq, Fawzia ^a   Del Monte, Federica ^a   Hajjar, Roger J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Gene transfer; Heart failure; Hypertrophy; Signaling pathways

Indexed keywords

ADENOVIRUS VECTOR; PROTEIN; TACROLIMUS;

ANIMAL CELL; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DNA VECTOR; GENE TRANSFER; HEART DISEASE; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0036956725     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2002.129249     Document Type: Conference Paper

References (99)

1. Massie BM, Shah NB: Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-712
2. Barry WH, Bridge JH: Intracellular calcium homeostasis in cardiac myocytes. Circulation 1993;87:1806-1815
3. Arai M, Matsui H, Periasamy M: Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res 1994;74:555-564
4. Aviv A: Recent advances in cellular Ca2+ homeostasis: implications to altered regulations of cellular Ca2+ and Na(+)-H+ exchange in essential hypertension. Curr Opin Cardiol 1996;11:477-482
5. Liao R, Helm PA, Hajjar RJ, Saha C, Gwathmey JK: [Ca2+]i in human heart failure: a review and discussion of current areas of controversy. Yale J Biol Med 1994;67: 247-264
6. Katz AM: The cardiomyopathy of overload: an unnatural growth response. Eur Heart J 1995;16(Suppl O):110-114
7. Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA: Myosin heavy chain gene expression in human heart failure. J Clin Invest 1997;100:2362-2370
8. Colucci WS: Molecular and cellular mechanisms of myocardial failure. Am J Cardiol 1997;80:15-25
9. Hajjar RJ, Gwathmey JK, Briggs GM, Morgan JP: Differential effect of DPI 201-106 on the sensitivity of the myofilaments to Ca2+ in intact and skinned trabeculae from control and myopathic human hearts. J Clin Invest 1988;82:1578-1584
10. Balke CW, Egan TM, Wier WG: Processes that remove calcium from the cytoplasm during excitation-contraction coupling in intact rat heart cells. J Physiol 1994;474:447-462
11. Wier WG, Lopez-Lopez JR, Shacklock PS, Balke CW: Calcium signaling in cardiac muscle cells. Ciba Found Symp 1995;188:146-160
12. Hasenfuss G: Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failure. Circ Res 1998;83:966-968
13. Koss KL, Kranias EG: Phospholamban: a prominent regulator of myocardial contractility. Circ Res 1996;79: 1059-1063
14. Gwathmey JK, Morgan JP: Sarcoplasmic reticulum calcium mobilization in right ventricular pressure-overload hypertrophy in the ferret: relationships to diastolic dysfunction and a negative treppe. Pflugers Arch 1993;422: 599-608
15. Gwathmey JK, Bentivegna LA, Ransil BJ, Grossman W, Morgan JP: Relationship of abnormal intracellular calcium mobilisation to myocyte hypertrophy in human ventricular myocardium. Cardiovasc Res 1993;27:199-203
16. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ: Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 1997;276:800-806
17. Schwartz K, Mercadier JJ: Molecular and cellular biology of heart failure. Curr Opin Cardiol 1996;11:227-236
18. Flesch M, Schwinger RH, Schnabel P, Schiffer F, van Gelder I, Bavendiek U, Sudkamp M, Kuhn-Regnier F, Bohm M: Sarcoplasmic reticulum Ca2+ATPase and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy. J Mol Med 1996;74:321-332
19. Flesch M, Schwinger RH, Schiffer F, Frank K, Sudkamp M, Kuhn-Regnier F, Arnold G, Bohm M: Evidence for functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in failing human myocardium. Circulation 1996;94:992-1002
20. Flesch M, Putz F, Schwinger RH, Bohm M: Functional relevance of an enhanced expression of the Na(+)-Ca2+ exchanger in the failing human heart. Ann N Y Acad Sci 1996;779:539-542
21. Bristow MR: Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 1997;80(Suppl 1):26L-40L
22. Lefkowitz RJ: G proteins in medicine. N Engl J Med 1995;332:186-187
23. Lefkowitz RJ, Pitcher J, Krueger K, Daaka Y: Mechanisms of beta-adrenergic receptor desensitization and resensitization. Adv Pharmacol 1998;42:416-420
24. Gauthier C, Tavernier G, Charpentier F, Langin D, Le Marec H: Functional beta3-adrenoceptor in the human heart. J Clin Invest 1996;98:556-562
25. Bohm M, Flesch M, Schnabel P: Beta-adrenergic signal transduction in the failing and hypertrophied myocardium. J Mol Med 1997;75:842-848
26. Muller FU, Boknik P, Knapp J, Luss H, Neumann J, Vahlensieck U, Bohm M, Deng MC, Scheld HH, Schmitz W: Quantification of the cAMP response element binding protein in ventricular nuclear protein from failing and nonfailing human hearts. Biochem Biophys Res Commun 1997;236:351-354
27. Bohm M, Flesch M, Schnabel P: Role of G-proteins in altered beta-adrenergic responsiveness in the failing and hypertrophied myocardium. Basic Res Cardiol 1996;91: 47-51
28. Lohse MJ, Engelhardt S, Danner S, Bohm M: Mechanisms of beta-adrenergic receptor desensitization: from molecular biology to heart failure. Basic Res Cardiol 1996;91:29-34
29. Flesch M, Erdmann E, Bohm M: Changes in beta-adrenoceptors and G-proteins during the transition from cardiac hypertrophy to heart failure. J Cardiol Fail 1996; 2(Suppl 4):S35-S43
30. Asano K, Dutcher DL, Port JD, Minobe WA, Tremmel KD, Roden RL, Bohlmeyer TJ, Bush EW, Jenkin MJ, Abraham WT, Raynolds MV, Zisman LS, Perryman MB, Bristow MR: Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation 1997;95:1193-2000
31. Rockman HA, Koch WJ, Milano CA, Lefkowitz RJ: Myocardial beta-adrenergic receptor signaling in vivo: insights from transgenic mice. J Mol Med 1996;74:489-495
32. Rockman HA, Choi DJ, Rahman NU, Akhter SA, Lefkowitz RJ, Koch WJ: Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc Natl Acad Sci U S A 1996;93:9954-9999
33. Bohm M: Alterations of beta adrenoceptor G-protein regulated adenyl cyclase in heart failure. Mol Cell Biochem 1995;147:147-160
34. Kyriakis JM, Avruch J: Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays 1996;18: 567-577
35. Pathophysiology of heart failure. In Braunwald E, Colucci W, eds. Heart disease: a textbook of cardiovascular medicine, 5th ed. Saunders, Philadelphia, PA, 1999, pp. 394-420
36. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM: Stress-activated protein kinases in cardiovascular disease. Circ Res 1996;78:947-953
37. Klee CB, Ren H, Wang X: Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 1998;273:13367-13370
38. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998;93:215-228
39. Sadoshima J, Izumo S: Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Circ Res 1995;77:1040-1052
40. Komuro L, Yazaki Y: Control of cardiac gene expression by mechanical stress. Annu Rev Physiol 1993;55:55-75
41. Yamazaki T, Yazaki Y: Is there major involvement of the rennin-angiotensin system in cardiac hypertrophy? Circ Res 1997;81:639-642
42. Pennica D, Shaw KJ, Swanson TA, Moore MW, Shelton DL, Zioncheck KA, Rosenthal A, Taga T, Paoni NF, Wood WI: Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J Biol Chem 1995;270:10915-10922
43. Parker TG, Packer SE, Schneider MD: Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest 1990;85:507-514
44. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y: Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-355
45. Chen L, Glover JN, Hogan PG, Rao A, Harrison SC: Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 1998;392:42-48
46. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR: Phosphorylation of c-jun mediated by MAP kinases. Nature 1991;353:670-674
47. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-16486
48. Choukroun G, Hajjar R, Kyriakis JM, Bonventre JV, Rosenzweig A, Force T: Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. J Clin Invest 1998;102:1311-1320
49. Liu Y, Cigola E, Cheng W, Kajstura J, Olivetti G, Hintze TH, Anversa P: Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 1995;73:771-787
50. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P: Stretch-induced programmed myocyte cell death. J Clin Invest 1995;96:2247-2259
51. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S: Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol 1996;148:141-149
52. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 1996;335:1182-1189
53. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 1994;94:1621-1628
54. Saraste A, Pulkki K, Kallajoki M, Henriksen K, Parvinen M, Voipio-Pulkki LM: Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-323
55. Yaoita H, Ogawa K, Maehara K, Maruyama Y: Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 1998;97:276-281
56. Gagliardini V, Fernandez PA, Lee RK, Drexler HC, Rotello RJ, Fishman MC, Yuan J: Prevention of vertebrate neuronal death by the crmA gene. Science 1994;263:826-828
57. Komiyama T, Ray CA, Pickup DJ, Howard AD, Thornberry NA, Peterson EP, Salvesen G: Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J Biol Chem 1994;269:19331-19337
58. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schulze-Osthoff K: Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 1995;375:81-83
59. Tewari M, Telford WG, Miller RA, Dixit VM: CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J Biol Chem 1995;270:22705-22708
60. Tewari M, Dixit VM: Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J Biol Chem 1995;270:3255-3260
61. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801- 809
62. Rodriguez-Tarduchy G, Collins MK, Garcia I, Lopez-Rivas A: Insulin-like growth factor-I inhibits apoptosis in IL-3-dependent hemopoietic cells. J Immunol 1992;149:535-540
63. Stewart CE, Rotwein P: Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 1996;271:1130-11338
64. Gluckman P, Klempt N, Guan J, Mallard C, Sirimanne E, Dragunow M, Klempt M, Singh K, Williams C, Nikolics K: A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury. Biochem Biophys Res Commun 1992;182:593-599
65. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME: Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997;275:661-665
66. Franke TF, Kaplan DR, Cantley LC: PI3K: Downstream AKTion blocks apoptosis. Cell 1997;88:435-437
67. Franke TF, Kaplan DR, Cantley LC, Toker A: Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 1997;275:665-668
68. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G: Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 1997;385:544-548
69. Kulik G, Klippel A, Weber MJ: Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997;17:1595-1606
70. Schmidt U, Hajar RJ: Gene therapy in heart failure. Best Pract Res Clin Anaesthesiol 2001;15(2):301-312
71. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998;95:2509-2914
72. Hajjar RJ, Schmidt U, Matsui T, Guerrero JL, Lee KH, Gwathmey JK, Dec GW, Semigran MJ, Rosenzweig A: Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A 1998;95:5251-5256
73. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T: Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 1993;73:1202-1207
74. Magovern CJ, Mack CA, Zhang J, Hahn RT, Ko W, Isom OW, Crystal RG, Rosengart TK: Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg 1996;62:425-434
75. Lee J, Laks H, Drinkwater DC, Blitz A, Lam L, Shiraishi Y, Chang P, Drake TA, Ardehali A: Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. J Thorac Cardiovasc Surg 1996;111:246-252
76. Kass-Eisler A, Falck-Pedersen E, Alvira M, Rivera J, Buttrick PM, Wittenberg BA, Cipriani L, Leinwand LA: Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A 1993;90:11498-11502
77. Westfall MV, Rust EM, Albayya F, Metzger JM: Adenovirus-mediated myofilament gene transfer into adult cardiac myocytes. Methods Cell Biol 1997;52:307-322
78. Westfall MV, Rust EM, Metzger JM: Slow skeletal troponin I gene transfer, expression, and myofilament incorporation enhances adult cardiac myocyte contractile function. Proc Natl Acad Sci U S A 1997;94:5444-5449
79. Hajjar RJ, Kang JX, Gwathmey JK, Rosenzweig A: Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. Circulation 1997;95:423-429
80. Hajjar RJ, Schmidt U, Kang JX, Matsui T, Rosenzweig A: Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circ Res 1997;81:145-153
81. del Monte F, Williams E, Lebeche D, Schmidt U, Rosenzweig A, Gwathmey JK, Lewandowski ED, Hajjar RJ: Improvement in surivial and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca (2+)-ATPase in a rat model of heart failure. Circulation 2001;104:1424-1429
82. Lim HW, Molkentin JD: Calcineurin and human heart failure. Nat Med 1999;5:246-247
83. Drazner MH, Peppel KC, Dyer S, Grant AO, Koch WJ, Lefkowitz RJ: Potentiation of beta-adrenergic signaling by adenoviral-mediated gene transfer in adult rabbit ventricular myocytes. J Clin Invest 1997;99:288-296
84. Akhter SA, Skaer CA, Kypson AP, McDonald PH, Peppel KC, Glower DD, Lefkowitz RJ, Koch WJ: Restoration of beta-adrenergic signaling in failing cardiac ventricular myocytes via adenoviral-mediated gene transfer. Proc Natl Acad Sci U S A 1997;94:12100-12105
85. Giordano FJ, He H, McDonough P, Meyer M, Sayen MR, Dillman WH: Adenovirus-mediated gene transfer reconstitutes depressed sarcoplasmic reticulum Ca2+-ATPase levels and shortens prolonged cardiac myocyte Ca2+ transients. Circulation 1997;96:400-403
86. Wang Y, Su B, Sah VP, Brown JH, Han J, Chien KR: Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 1998;273:5423-5426
87. Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, Chien KR: Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998;273:2161-2168
88. Zechner D, Thuerauf DJ, Hanford DS, McDonough PM, Glembotski CC: A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J Cell Biol 1997;139:115-127
89. Force T, Hajjar R, del Monte F, Rosenzweig A, Choukroun G: Signaling pathways mediating the response to hypertrophic stress in the heart. Gene Expr 1999;7:337-348
90. Whitmarsh AJ, Yang SH, Su MS, Sharrocks AD, Davis RJ: Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol Cell Biol 1997;17:2360-2371
91. Beals CR, Sheridan CM, Turck CW, Gardner P, Crabtree GR: Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 1997;275:1930-1934
92. Jung Y, Miura M, Yuan J: Suppression of interleukin-1 beta-converting enzyme-mediated cell death by insulin-like growth factor. J Biol Chem 1996;271:5112-5117
93. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr: Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest 1995;95:619-627
94. Cheng W, Reiss K, Li P, Chun MJ, Kajstura J, Olivetti G, Anversa P: Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fischer 344 rats. Circ Res 1996;78:536-546
95. Young LH, Renfu Y, Hu X, Chong S, Hasan S, Jacob R, Sherwin RS: Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat. Am J Physiol 1999;276(1 Pt 1):E143-E150
96. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS: Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells. Kidney Int 1994;45:598-604
97. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P: Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest 1997;100:1991-1999
98. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS: Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation 1996;93:800-809
99. American Heart Association. Available from: URL:http: //www.american.org